News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Daily News Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care L.A. McKeown November 29, 2018
News Daily News Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women L.A. McKeown October 12, 2018
News Daily News Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’ Todd Neale September 13, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Daily News Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows Michael O'Riordan April 05, 2018
News Daily News Time for Guidelines to Recommend ARBs Over ACE Inhibitors? Shelley Wood March 29, 2018
News Conference News ACC 2018 Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure Shelley Wood March 12, 2018
News Conference News AHA 2017 Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation Yael L. Maxwell November 27, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist Yael L. Maxwell January 23, 2017
News Daily News Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients Michael O'Riordan January 17, 2017
News Daily News Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge Michael O'Riordan September 30, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News When Industry Pays for Meals, Physicians Are More Likely to Prescribe Certain Brand-name Drugs Caitlin E. Cox June 22, 2016
News Daily News Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients Yael L. Maxwell November 04, 2015
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015